| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |